Walleye Capital’s Abiomed Inc ABMD Stock Holding History

Walleye Capital’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,300	Closed	-$319K	–	3877
2022 Q3	$319K	Buy	+1,300	New	+$351K	0.01%	1797
2020 Q1	–	Sell	-3,700	Closed	-$631K	–	1898
2019 Q4	$631K	Sell	3,700 -5,200	-58%	-$964K	0.04%	580
2019 Q3	$1.58M	Buy	8,900 +1,200	+16%	+$259K	0.09%	289
2019 Q2	$2.01M	Buy	7,700 +5,700	+285%	+$1.51M	0.22%	91
2019 Q1	$571K	Buy	+2,000	New	+$665K	0.09%	343

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Walleye Capital's ABMD Position: Q4 2022 in Review

Walleye Capital sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,254 shares — an estimated $308K sold.

Walleye Capital first reported a position in ABMD in Q1 2019 and held it in 6 quarters. The position peaked at $2M in Q3 2019. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Walleye Capital reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Walleye Capital sold 1,254 Abiomed Inc shares in Q4 2022, an estimated $308K.
Walleye Capital first reported a position in Abiomed Inc in Q1 2019 and held it in 6 quarters.
Walleye Capital's Abiomed Inc position peaked at $2M in Q3 2019.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Walleye Capital's 13F filing for Q4 2022, filed 14 Feb 2023.